Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - BIOMARIN PHARMACEUTICAL INC | bmrn-ex321_7.htm |
| EX-31.2 - EX-31.2 - BIOMARIN PHARMACEUTICAL INC | bmrn-ex312_6.htm |
| EX-31.1 - EX-31.1 - BIOMARIN PHARMACEUTICAL INC | bmrn-ex311_12.htm |
| EX-23.1 - EX-23.1 - BIOMARIN PHARMACEUTICAL INC | bmrn-ex231_11.htm |
| EX-10.50 - EX-10.50 - BIOMARIN PHARMACEUTICAL INC | bmrn-ex1050_653.htm |
| EX-10.49 - EX-10.49 - BIOMARIN PHARMACEUTICAL INC | bmrn-ex1049_495.htm |
| EX-2.6 - EX-2.6 - BIOMARIN PHARMACEUTICAL INC | bmrn-ex26_494.htm |
| 10-K - 10-K - BIOMARIN PHARMACEUTICAL INC | bmrn-10k_20161231.htm |
Exhibit 21.1
Subsidiaries of BioMarin Pharmaceutical Inc. as of December 31, 2016
|
Name |
|
Direct Parent(s) |
|
|
Ownership |
|
|
Jurisdiction of Incorporation |
|
|
BioMarin UK Ltd. |
|
BioMarin Pharmaceutical Inc. |
|
|
100 |
% |
|
United Kingdom |
|
|
BioMarin GALNS Ltd. |
|
BioMarin Pharmaceutical Inc. |
|
|
100 |
% |
|
Ireland |
|
|
BioMarin International Holdings, Inc. |
|
BioMarin Pharmaceutical Inc. |
|
|
100 |
% |
|
Delaware |
|
|
BioMarin International Ltd. |
|
BioMarin GALNS Ltd. |
|
|
100 |
% |
|
Ireland |
|